Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Eur J Pharmacol ; 887: 173438, 2020 Nov 15.
Article in English | MEDLINE | ID: mdl-32795515

ABSTRACT

Despite advances in medical therapy, pulmonary arterial hypertension (PAH) remains an inexorably progressive and highly lethal disease. Signal transducer and activator of transcription (STAT)-3 is one of the main intracellular transcription factors implicated in PAH vascular remodeling. We hypothesized that niclosamide, a STAT3 inhibitor, would reduce vascular remodeling in an established pulmonary arterial hypertension model, thus enhancing cardiac function. Male Wistar rats were treated either with monocrotaline (60 mg/kg), to induce PAH, or saline (C group) by intraperitoneal injection. On day 14, PAH animals were randomly assigned to receive oral (1) saline (PAH-SAL); (2) niclosamide (75 mg/kg/day) (PAH-NICLO); (3) sildenafil (20 mg/kg/day) (PAH-SIL); or (4) niclosamide + sildenafil (PAH-NICLO + SIL), once daily for 14 days. On day 28, right ventricular systolic pressure was lower in all treated groups compared to PAH-SAL. Pulmonary vascular collagen content was lower in PAH-NICLO (37 ± 3%) and PAH-NICLO + SIL (37 ± 6%) compared to PAH-SAL (68 ± 4%), but not in PAH-SIL (52 ± 1%). CD-34, an endothelial cell marker, was higher, while vimentin, a mesenchymal cell marker, was lower in PAH-NICLO and PAH-NICLO + SIL compared to PAH-SAL, suggesting attenuation of endothelial-mesenchymal transition. Expression of STAT3 downstream targets such as transforming growth factor (TGF)-ß, hypoxia-inducible factor (HIF)-1, and provirus integration site for Moloney murine leukemia virus (PIM-1) in lung tissue was reduced in PAH-NICLO and PAH-NICLO + SIL compared to PAH-SAL. In conclusion, niclosamide, with or without sildenafil, mitigated vascular remodeling and improved right ventricle systolic pressure. This new role for a well-established drug may represent a promising therapy for PAH.


Subject(s)
Lung/blood supply , Lung/drug effects , Niclosamide/therapeutic use , Pulmonary Arterial Hypertension/prevention & control , Vascular Remodeling/drug effects , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Lung/pathology , Male , Monocrotaline/toxicity , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/pathology , Niclosamide/pharmacology , Pulmonary Arterial Hypertension/chemically induced , Pulmonary Arterial Hypertension/pathology , Rats , Rats, Wistar , Vascular Remodeling/physiology
2.
PLoS Negl Trop Dis ; 14(1): e0007873, 2020 01.
Article in English | MEDLINE | ID: mdl-31945055

ABSTRACT

BACKGROUND: Preventive chemotherapy is a useful tool for the control of Taenia solium taeniasis and cysticercosis. The aim of this systematic review is to assess the scientific evidence concerning the effectiveness and safety of different drugs in preventive chemotherapy for T. solium taeniasis in endemic populations. METHODS: A systematic review was conducted of controlled and uncontrolled studies, assessing the efficacy and adverse effects (among other outcomes) of albendazole, niclosamide and/or praziquantel for preventive chemotherapy of T. solium taeniasis. A comprehensive search was conducted for published and unpublished studies. Two reviewers screened articles, completed the data extraction and assessment of risk of bias. A meta-analysis of cure rate and relative reduction in prevalence was performed. The protocol for this review was registered on the International prospective register of systematic reviews (PROSPERO), number CRD42018112533. RESULTS: We identified 3555 records, of which we included 20 primary studies reported across 33 articles. Meta-analyses of drug and dose showed that a single dose of praziquantel 10mg/kg, albendazole 400mg per day for three consecutive days, or niclosamide 2g, resulted in better cure rates for T. solium taeniasis (99.5%, 96.4% and 84.3%, respectively) than praziquantel 5mg/kg or single dose albendazole 400mg (89.0% and 52.0%, respectively). These findings have a low certainty of evidence due to high risk of bias in individual studies and heterogeneity in combined estimates. In relation to side-effects, most studies reported either no or only mild and transient side-effects within the first three days following drug administration for all drugs and doses. CONCLUSION: Evidence indicated that praziquantel 10mg/kg, niclosamide 2g, and triple dose albendazole 400mg were effective as taenicides and could be considered for use in mass drug administration programs for the control of T. solium taeniasis. Evidence was not found that any of these drugs caused severe side effects at the indicated doses, although the extent of the available evidence was limited.


Subject(s)
Anticestodal Agents/therapeutic use , Chemoprevention/methods , Taenia solium/drug effects , Taeniasis/drug therapy , Albendazole/therapeutic use , Animals , Cysticercosis/drug therapy , Cysticercosis/prevention & control , Humans , Niclosamide/therapeutic use , Praziquantel/therapeutic use , Taeniasis/prevention & control
3.
Prensa méd. argent ; Prensa méd. argent;105(5): 309-316, jun 2019. tab, fig
Article in English | BINACIS, LILACS | ID: biblio-1024643

ABSTRACT

Ulcerative colitis is an idiopathic chronic inflammatory disease of the colon for which a lot of treatment modalities are present. However, significant side effects are associated with them, and there is a need for a search for other tretment options. This study was aimed to assess the contribution of niclosamide in experimentally established colitis in rats. Animals were categorized into 5 groups; the control group undergoes no induction of UC, colitis group in which UC was induced, and animals receive no treatment, the niclosamide group that received niclosamide and sulfasalazine group that received sulfasalazine. Each group was composed of 10 animals. After the completion of a one-month period of the experiment animals were sacrificed and the following meausres were done: the weight of the colon, determination of the area of mucosal damage by mm2, histological scoring after hematoxylin and eosin stain together with MAC score and immunohistochemistry of IL-6, TNF-alpha, MPO, MDA, CD62, and ICAM1. The results of the current study revealed that Nicosamide was able to reduce the area of mucosal damage, colon weight, histological and Mac scores and immunohistochemical scores of inflammatory and oxidative markers, significantly when contrasted to a group of colitis (P< 0.05). It has been concluded that Niclosamide was proved to have a significant effect as an adjuvant mode of therapy for colitis through its, anti-inflamatory and anti-oxidant effects (AU)


Subject(s)
Rats , Sulfasalazine/therapeutic use , Colitis, Ulcerative/therapy , Rebound Effect , Evaluation of Results of Therapeutic Interventions , Time-to-Treatment , Animal Culling , Niclosamide/therapeutic use
4.
J Parasitol ; 104(5): 574-575, 2018 10.
Article in English | MEDLINE | ID: mdl-30019983

ABSTRACT

We provide the first report of Acanthocephala ( Prosthenorchis elegans) in Mexican non-human primates. There has been no known treatment against this parasite except for surgical removal, and this has been relatively ineffective because of the small juveniles. We report the presence of P. elegans in a captive breeding colony of squirrel monkeys ( Saimiri sciureus) in Mexico, and we describe a successful treatment protocol. Treatment involved 2 steps: oral administration of the drugs loperamide chlorhydrate (0.5 mg/0.9 kg/3 days) and niclosamide (0.2 mg/0.9 kg/3 days) followed by surgical removal of adult worms from the intestine. Fecal examination during treatment revealed live adults but no living juveniles and no eggs. Surgery after 1 wk of treatment revealed the presence of adults and an absence of juvenile parasites. All adults were physically extracted during the surgery. All subjects recovered from surgery within 1 wk.


Subject(s)
Acanthocephala , Helminthiasis, Animal/therapy , Monkey Diseases/parasitology , Monkey Diseases/therapy , Saimiri/parasitology , Animals , Anthelmintics/therapeutic use , Cockroaches/parasitology , Disease Outbreaks/veterinary , Drug Therapy, Combination/veterinary , Feces/parasitology , Feeding Behavior , Female , Helminthiasis, Animal/epidemiology , Helminthiasis, Animal/parasitology , Intestinal Diseases, Parasitic/epidemiology , Intestinal Diseases, Parasitic/parasitology , Intestinal Diseases, Parasitic/therapy , Intestinal Diseases, Parasitic/veterinary , Intestinal Mucosa/parasitology , Intestinal Mucosa/surgery , Loperamide/therapeutic use , Male , Mexico/epidemiology , Monkey Diseases/epidemiology , Neoptera/parasitology , Niclosamide/therapeutic use
5.
PLoS Negl Trop Dis ; 8(9): e3125, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25210748

ABSTRACT

BACKGROUND: Taenia solium is a major cause of preventable epilepsy in developing nations. Screening and treatment of human intestinal stage infection (taeniasis) within high-risk foci may reduce transmission and prevent epilepsy by limiting human exposure to infective eggs. We piloted a ring-strategy that involves screening and treatment for taeniasis among households located nearby pigs heavily-infected with the larval stage (cysticercosis). These pigs mark areas of increased transmission and can be identified by tongue examination. METHODOLOGY: We selected two villages in northern Peru for a controlled prospective interventional cohort pilot study. In the intervention village (1,058 residents) we examined the tongues of all pigs every 4 months for nodules characteristic of cysticercosis. We then screened all residents living within 100-meters of any tongue-positive pig using enzyme-linked immunosorbent assay to detect Taenia antigens in stool. Residents with taeniasis were treated with niclosamide. In both the intervention and control (753 residents) we measured incidence of exposure by sampling the pig population every 4 months for serum antibodies against cysticercosis using enzyme-linked immunoelectrotransfer blot. PRINCIPAL FINDINGS: Baseline seroincidence among pigs born during the study was 22.6 cases per 100 pigs per-month (95% confidence interval [CI] 17.0-30.0) in the intervention and 18.1 (95% CI 12.7-25.9) in the control. After one year we observed a 41% reduction in seroincidence in the intervention village compared to baseline (incidence rate ratio 0.59, 95% CI 0.41-0.87) while the seroincidence in the control village remained unchanged. At study end, the prevalence of taeniasis was nearly 4 times lower in the intervention than in the control (prevalence ratio 0.28, 95% CI 0.08-0.91). CONCLUSIONS/SIGNIFICANCE: Ring-screening reduced transmission of T. solium in this pilot study and may provide an effective and practical approach for regions where resources are limited. However, this strategy requires validation in larger populations over a greater period of time.


Subject(s)
Antibodies, Helminth/blood , Swine Diseases/parasitology , Taenia solium , Taeniasis/veterinary , Tongue/parasitology , Animals , Anticestodal Agents/therapeutic use , Child, Preschool , Cysticercosis/epidemiology , Feces , Female , Humans , Incidence , Male , Niclosamide/therapeutic use , Peru/epidemiology , Pilot Projects , Prevalence , Prospective Studies , Swine , Swine Diseases/epidemiology , Taeniasis/epidemiology , Taeniasis/transmission , Zoonoses
6.
Am J Trop Med Hyg ; 73(3): 496-500, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16172470

ABSTRACT

Taenia solium taeniasis/cysticercosis is endemic in most developing countries, where it is an important cause of epileptic seizures and other neurologic symptoms. In industrialized countries, cysticercosis results from travel or immigration of tapeworm carriers from endemic areas. In both endemic and nonendemic countries, housemaids commonly immigrate from cysticercosis-endemic areas and can transmit the infection if they carry the adult tapeworm. Between July 2001 and July 2002, 1,178 housemaids (961 of them work in the top five most affluent districts of Lima, a metropolis of 8 million inhabitants considered nonendemic for cysticercosis) were evaluated for serum antibodies to Taenia solium and stool microscopy for taeniasis and cysticercosis. The serosurvey revealed a prevalence of cysticercosis-specific antibodies of 14.6% (95% CI: 12.6-16.6%), and stool microscopy detected 12 T. solium tapeworm carriers, for a prevalence of taeniasis of 1.2% (95% CI: 0.6-1.8%). A nonrandom sample of 26 seropositive housemaids was examined by brain CT and 50% of them had brain lesions compatible with neurocysticercosis, mainly calcifications. From the families who used a tapeworm-carrier housemaid, cysticercosis antibodies were detected in 6 (23%) of 26 persons who agreed to participate. One seropositive member of the employer families was symptomatic for seizures and had brain calcifications. The prevalence of tapeworm infections in this housemaid group is similar to levels in endemic areas, constituting a source of neurocysticercosis infection.


Subject(s)
Cysticercosis/epidemiology , Taeniasis/epidemiology , Adolescent , Adult , Anthelmintics/therapeutic use , Antibodies, Helminth/blood , Female , Humans , Niclosamide/therapeutic use , Peru/epidemiology , Seroepidemiologic Studies
7.
Lancet ; 363(9413): 949-50, 2004 Mar 20.
Article in English | MEDLINE | ID: mdl-15043964

ABSTRACT

Identification of species of human tapeworms is crucial because the consequences of infection by Taenia solium and T saginata are very different. However, evacuation of species-identifiable tapeworms is uncommon and Taenia spp eggs are indistinguishable under the microscope. Treatment of taeniasis consists of niclosamide followed by a purgative. Recently, we adopted preniclosamide and postniclosamide electrolyte-polyethyleneglycol salt (EPS) purges to improve bowel cleaning. Retrospective comparison of traditional castor oil with EPS purge showed that recovery of the tapeworm scolex was significantly improved (20 of 68 vs none of 46, p=0.0001) in the EPS group. Furthermore, 42 of 68 (62%) individuals receiving EPS excreted identifiable gravid proglottids. EPS treatment helps the visual identification of Taenia spp.


Subject(s)
Taenia saginata/isolation & purification , Taenia solium/isolation & purification , Taeniasis/drug therapy , Taeniasis/parasitology , Adolescent , Adult , Aged , Anticestodal Agents/therapeutic use , Cathartics/administration & dosage , Child , Combined Modality Therapy , Feces/parasitology , Humans , Middle Aged , Niclosamide/therapeutic use , Polyethylene Glycols/administration & dosage , Taeniasis/diagnosis
8.
Rev. chil. pediatr ; 70(2): 126-9, mar.-abr. 1999. ilus
Article in Spanish | LILACS | ID: lil-244026

ABSTRACT

Dypilidium caninum es un cestode común en perros y gatos distribuido en todo el mundo. El ser humano, huesped accidental, adquiere la infección a través de las pulgas en asociación con las mascotas infectadas, siendo esta enfermedad más frecuente en niños. Presentamos el caso de una niña de un año y medio de edad, que durante siete meses eliminó proglótidas en las deposiciones, consultando en numerosas oportunidades siendo tratada con fármacos dirigidos a protozoos y nematelmintos. Finalmente, luego de la identificación del Dypilidium caninum se trató a la paciente con niclosamida, evolucionando satisfactoriamente


Subject(s)
Humans , Female , Infant , Cestoda/pathogenicity , Cestode Infections/etiology , Animals, Domestic/parasitology , Cestoda/isolation & purification , Cestode Infections/diagnosis , Cestode Infections/drug therapy , Cestode Infections/transmission , Disease Reservoirs , Feces/parasitology , Niclosamide/therapeutic use
9.
Vet Q ; 20(2): 69-72, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9563164

ABSTRACT

The anthelmintic efficacy and safety of the oxibendazole component in a combination oxibendazole-niclosamide paste were investigated in dogs and cats and in litters of pups with naturally acquired nematode infections. A single dose of 15 mg oxibendazole/kg body weight given to 70 dogs and to 29 cats reduced faecal worm egg counts (EPG) by 97.6% for Toxocara canis, 95.7% for Trichuris vulpis, 94.6% for Ancylostoma caninum, and 100% for Toxascaris leonina. In cats, 96.7% efficacy was demonstrated against Toxocara cati. In a second trial, 119 pups in 22 litters were treated with the same dosage at 2, 4, and 6 weeks of age. After treatment on two consecutive days, 95% of the pups did not shed T. canis eggs, compared with 85% after only a single treatment. Side effects were rare and only recorded in young animals. A 2-day treatment schedule is recommended for unweaned pups.


Subject(s)
Anthelmintics/therapeutic use , Benzimidazoles/therapeutic use , Cat Diseases/drug therapy , Dog Diseases/drug therapy , Intestinal Diseases, Parasitic/veterinary , Nematode Infections/veterinary , Ancylostoma/drug effects , Animals , Animals, Newborn , Antinematodal Agents/therapeutic use , Cats , Dogs , Drug Combinations , Feces/parasitology , Female , Intestinal Diseases, Parasitic/drug therapy , Male , Nematode Infections/drug therapy , Netherlands , Niclosamide/therapeutic use , Parasite Egg Count/veterinary , Suriname , Toxascaris/drug effects , Toxocara canis/drug effects , Trichuris/drug effects
10.
Trans R Soc Trop Med Hyg ; 91(5): 595-8, 1997.
Article in English | MEDLINE | ID: mdl-9463679

ABSTRACT

Mass treatment of the human population with niclosamide was carried out in 2 villages in rural Guatemala where Taenia solium was endemic, to determine how this would affect the epidemiology of the parasite. Intestinal taeniasis was diagnosed by microscopy and coproantigen testing, and porcine cysticercosis by a specific Western blot. Before mass treatment, the prevalence of human taeniasis was 3.5%; 10 months after treatment it was 1%, a significant decrease (P < 10(-4)). All tapeworms that could be identified to the species level were T. solium. Similarly, the seroprevalence of antibodies to cysticercosis in pigs declined from 55% before treatment to 7% 10 months after treatment, once again a significant decrease (P < 10(-6)). These effects were seen in both villages. The possible use of mass chemotherapy as a tool in the control of T. solium is discussed.


Subject(s)
Anticestodal Agents/therapeutic use , Cysticercosis/veterinary , Endemic Diseases , Niclosamide/therapeutic use , Swine Diseases/epidemiology , Taeniasis/drug therapy , Animals , Cysticercosis/epidemiology , Guatemala/epidemiology , Humans , Prevalence , Seroepidemiologic Studies , Swine , Swine Diseases/drug therapy , Taeniasis/epidemiology
11.
Salvador; s.n; 1995. 127 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: lil-195771

ABSTRACT

O desenvolvimento da forma hepatatoesplênica da esquistossomose mansônica, ainda näo foi completamente esclarecido. Geralmente säo invocadas a intensidade da carga parasitária, as reinfecçöes sucessivas ou periódicas, a resposta imunológica do hospedeiro, a raça e a terapêutica específica, como fatores marcantes para explicar a razäo pela qual, somente pequeno percentual dos parasitados desenvolve essa forma de doença. O presente trabalho faz parte do "Projeto sobre Esquistossomose na Chapada Diamantina - Bahia - Brasil", tendo como objetivo contribuir para o conhecimento do papel das variáveis intensidade de carga parasitária, reinfecçöes sucessivas, terapêutica específica e raça, no desenvolvimento da forma hepatoesplênica, por ser esta, a mais frequênte das formas graves da doença. Um programa de controle da esquistossomose foi desenvolvido em uma área hiperendêmica de esquistossomose, através do uso de moluscicida durante dez anos, com a ajuda da comunidade local. Exames clínicos e parasitológicos de fezes foram realizados antes, durante o período de interrupçäo da transmissäo e após o retorno da transmissäo da parasitose. Ao longo dos quinze anos de seguimento dessa populaçäo, algumas pessoas fizeram uso de medicaçäo anti-esquissomótica, por demanda espontânea e outras näo. A avaliaçäo parasitológica foi feita através os exames de fezes qualitativo e quantitativo, determinando a prevalência e a intensidade da carga parasitária, pelo número de ovos eliminados nas fezes e sua média geométrica. A avaliaçäo da evoluçäo clínica foi feita pela análise do tamanho do fígado e do baço, e pela classificaçäo das formas clínicas, comparando-se o exame inicial com os exames subsequentes. Os principais parâmetros clínicos de evoluçäo - hepatomegalia, esplenomegalia e forma hepatoesplênica - foram analisados em relaçäo à populaçäo geral e ao tratamento específico. Em cada uma dessas situaçöes, os dados foram analisados de acordo com a idade e a raça. O processamento e a análise dos dados foram feitos de acordo com o modelo estatístico mais apropriado para determinado caso, utilizando-se pacotes estatísticos adequados e considerando-se como significante o encontro de p menor que 0,05. Os resultados obtidos permitem confirmar que a intensidade da carga parasitária está diretamente relacionada com o desenvolvimento da forma hepatoesplênica e que o grupo racial negro apresenta maior resistência a desenvolver esta forma clínica da doença...


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Niclosamide/therapeutic use , Oxamniquine/therapeutic use , Praziquantel/therapeutic use , Schistosoma mansoni/immunology , Schistosoma mansoni/parasitology , Schistosomiasis mansoni/complications , Schistosomiasis mansoni/drug therapy , Biomphalaria/immunology , Biomphalaria/parasitology , Brazil , Hepatomegaly/etiology , Splenomegaly/etiology
12.
Mem Inst Oswaldo Cruz ; 87 Suppl 4: 281-9, 1992.
Article in English | MEDLINE | ID: mdl-1343909

ABSTRACT

A 1% (W/V) formulation of Niclosamide (2', 5-Dichloro-4-nitrosalicylanilide) (TAP) was tested on Cebus apella monkeys as a topical prophylactic against schistosomiasis mansoni. Two experiments were conducted using the same formulation. In the first experiment, the TAP provided complete protection against schistosomiasis for 3 days. Of the 4 monkeys treated with TAP 7 days before exposure to Schistosoma mansoni cercariae, 2 were completely protected. The remaining 2 monkeys of the 7 day treatment group had a 78% or greater reduction in adult worm burdens when compared to the placebo treated monkeys. The second experiment was designed to determine the time between day 3 and 7 when the TAP no longer provided complete protection. However, all of the TAP treated monkeys in this experiment were completely protected, even the monkeys treated 7 days earlier. In both experiments, all monkeys used as infection controls and those receiving only the placebo became infected and showed typical experimental schistosomiasis. These results demonstrate that the TAP could provide fast acting, short-term protection to people who must enter cercariae infested water.


Subject(s)
Niclosamide/administration & dosage , Schistosoma mansoni/drug effects , Schistosomiasis mansoni/prevention & control , Administration, Topical , Animals , Cebus , Drug Resistance , Female , Larva , Male , Niclosamide/pharmacology , Niclosamide/therapeutic use , Oxamniquine/pharmacology , Schistosoma mansoni/growth & development , Schistosoma mansoni/isolation & purification , Schistosomiasis mansoni/parasitology
13.
Am J Trop Med Hyg ; 46(1): 85-8, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1536389

ABSTRACT

A case of neurocysticercosis in a six-year-old Mexican boy and a case of Taenia solium taeniasis in his five-year-old brother are reported. Neurocysticercosis was suspected based on clinical findings and was confirmed by computed tomography scanning. A parasitologic examination with zinc-sulfate flotation and formalin-ether sedimentation techniques was carried out on the whole family, and revealed Taenia sp. eggs in three stool samples from the five-year-old boy. The entire family agreed to undergo chemotherapy with niclosamide, but only the child passing taeniid eggs eliminated T. solium. No additional taeniasis cases were found in an examination of 20% of the village population, using the same parasitologic techniques. The results of an ELISA using cysticercus antigens were negative for the boy with neurocysticercosis, for other family members, and for 24 village volunteers, but were positive for the T. solium tapeworm carrier. It was concluded that in this family, person-to-person transmission of the tapeworm occurred due to poor living conditions and hygiene.


Subject(s)
Brain Diseases/parasitology , Cysticercosis/diagnosis , Taeniasis/diagnosis , Animals , Child , Child, Preschool , Cysticercosis/drug therapy , Feces/parasitology , Humans , Male , Mexico , Niclosamide/therapeutic use , Rural Health , Swine/parasitology , Taeniasis/drug therapy
14.
Parasitol. día ; 15(1/2): 32-6, ene.-jun. 1991. tab
Article in Spanish | LILACS | ID: lil-104910

ABSTRACT

Con el objeto de evaluar las características clínicas, epidemiológicas y bioquímicas de esta infección en población infantil, se estudió a 55 niños infectados exclusivamente por Hymenolepis nana y que consultaron en forma consecutiva al Policlínico de Parasitología del Hospital Luis Calvo Mackenna. La edad promedio de ellos fue de 6 años 6 meses. A todos se les indicó una completa anamnesis, examen físico, examen coproparasitológico seriado de deposiciones, hemograma, carotinemia y proteinemia. Fueron tratados con niclosamida en dosis de 2g el 1- día y 1 g/día hasta completar 7 días de tratamiento, repitiéndose los controles y estudios ya enunciados al mes siguiente. Los síntomas más frecuentes resultaron dolor abdominal 74,5%, meteorismo 52,7%, diarrea crónica 49,1%, y falta de progreso ponderal en el 32,7%. El tratamiento fue efectivo sólo en el 74,5%de los niños. Las proteínas plasmáticas fueron normales en la totalidad de los casos infectados y un 20%presentó niveles de caroteno bajo 60 mg/dl las que se normalizaron una vez tratada la parasitosis. El 49%presentó eosinofilia que en promedio fue de 768 eosinófilos/ul. Los pacientes tratados subieron 1,4 kg en un lapso de 2 meses. Se destaca la importancia de la adecuada sospecha y tratamiento de esta parasitosis


Subject(s)
Feces/analysis , Hymenolepiasis/diagnosis , Hymenolepis , Hymenolepiasis/drug therapy , Niclosamide/therapeutic use
15.
J La State Med Soc ; 141(3): 23-4, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2703751

ABSTRACT

Hymenolepsis diminuta is a tapeworm which is an intestinal parasite of rats and mice. Rarely, through accidental ingestion of an infected arthropod, man can become the definitive host. This report documents, for the first time, that such infections occur in Jamaica, West Indies. The life cycle of the parasite and its treatment are also discussed.


Subject(s)
Feces/parasitology , Hymenolepiasis/diagnosis , Intestinal Diseases, Parasitic/diagnosis , Female , Humans , Hymenolepiasis/drug therapy , Infant , Intestinal Diseases, Parasitic/drug therapy , Jamaica , Niclosamide/therapeutic use
16.
J La State Med Soc ; 141(3): 23-4, Mar. 1989.
Article in English | MedCarib | ID: med-12248

ABSTRACT

Hymenolepis diminuta is a tapeworm which is an intestinal parasite of rats and mice. Rarely, through accidental ingestion of an infected arthropod, man can become the definitive host. This report documents, for the first time, that such infections occur in Jamaica, West Indies. The life cycle of the parasite and its treatment are also discussed. (AU)


Subject(s)
Humans , Infant , Female , Feces/parasitology , Hymenolepiasis/diagnosis , Intestinal Diseases, Parasitic/diagnosis , Hymenolepiasis/drug therapy , Intestinal Diseases, Parasitic/drug therapy , Jamaica , Niclosamide/therapeutic use
17.
Rev Saude Publica ; 23(1): 45-57, 1989 Feb.
Article in Spanish | MEDLINE | ID: mdl-2814310

ABSTRACT

In the Valdivia (Chile) river basin 1,295 inhabitants of 6 riverside districts were examined between March and October 1987 and showed a 1.2% of prevalence by Diphyllobothrium in the districts of Riñihue and Las Huellas. Prevalence of 5.3% and 9.8% respectively were registered in dogs of the districts of Riñihue and Malihue. No cat or pig infection was observed in the different districts. The parasites recovered after the treatment were identified as Diphyllobothrium latum. Human infection by D. latum in the districts affected results from the consumption of smoked or insufficiently cooked fish. The investigation of 1,450 fish (4 exotic species and 11 autochthonous ones), caught in the Valdivia river basin in 1986 and 1987, showed the existence of plerocercoids of D. latum and/or Diphyllobothrium dendriticum in Salmo gairdneri and Salmo trutta among exotic fish and in some autochthonous species. Prevalence and mean intensity in the infection of fish as well as the degree of aggregation in the infrapopulations varied in the different districts. Some species of fish would act as intermediary hosts and others as paratenic hosts in the life cycles of Diphyllobothrium spp. in the Valdivia river basin. An improvement in the conditions of basic sanitation, in sanitary education and in the treatment of infected persons is proposed as a means for the control of diphyllobothriasis in the districts affected.


Subject(s)
Diphyllobothriasis/epidemiology , Diphyllobothrium/isolation & purification , Salmonidae/parasitology , Adult , Animals , Child , Child, Preschool , Chile , Diphyllobothriasis/drug therapy , Diphyllobothriasis/transmission , Disease Vectors , Dogs , Feces/parasitology , Female , Humans , Male , Middle Aged , Niclosamide/therapeutic use , Oxamniquine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL